Cargando…
Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease (COVID-19) has spread pandemically with high rates of morbidity and mortality. COVID-19 has also posed unprecedented challenges in terms of rapid development of pharmacological countermeasures to prevent or contrast SARS-Co...
Autores principales: | Ramirez, Giuseppe A., Gerosa, Maria, Bellocchi, Chiara, Arroyo-Sánchez, Daniel, Asperti, Chiara, Argolini, Lorenza M., Gallina, Gabriele, Cornalba, Martina, Scotti, Isabella, Suardi, Ilaria, Moroni, Luca, Beretta, Lorenzo, Bozzolo, Enrica P., Caporali, Roberto, Dagna, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527378/ https://www.ncbi.nlm.nih.gov/pubmed/37759674 http://dx.doi.org/10.3390/biom13091273 |
Ejemplares similares
-
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort
por: Gerosa, Maria, et al.
Publicado: (2022) -
Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year
por: Ramirez, Giuseppe A., et al.
Publicado: (2021) -
COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients
por: Ramirez, Giuseppe A., et al.
Publicado: (2020) -
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study
por: Gerosa, Maria, et al.
Publicado: (2022) -
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study
por: Moroni, Luca, et al.
Publicado: (2022)